Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cell cycle process	HORMAD2 NCAPD3 ATR HUS1 BTBD18 RTTN APEX1 MED1 ZNF365 ZNF503 FANCA ESCO2 CCNG2 MEI4 NEK1 LATS1 KLHDC3 RAD1 SVIL TTL CDC25B ESPL1 PLK4 DYNC1H1 HTT TBCE CDK6	2.50e-06	1441	145	27	GO:0022402
GeneOntologyCellularComponent	microtubule organizing center	HORMAD2 FLII RTTN APEX1 ZNF365 CEP350 EFHC2 DNAAF2 NEK1 LATS1 UBN1 NLRC5 CDC25B ESPL1 PLK4 DYNC1H1 HTT CDK6	8.27e-05	919	147	18	GO:0005815
GeneOntologyCellularComponent	centrosome	HORMAD2 FLII RTTN APEX1 ZNF365 CEP350 NEK1 LATS1 UBN1 NLRC5 CDC25B ESPL1 PLK4 DYNC1H1 CDK6	3.54e-04	770	147	15	GO:0005813
GeneOntologyCellularComponent	condensed nuclear chromosome	HORMAD2 NCAPD3 HUS1 MEI4 RAD1	4.60e-04	91	147	5	GO:0000794
GeneOntologyCellularComponent	checkpoint clamp complex	HUS1 RAD1	4.84e-04	5	147	2	GO:0030896
GeneOntologyCellularComponent	XY body	ATR ESCO2 PLK4	5.44e-04	23	147	3	GO:0001741
HumanPheno	Abnormality of the musculature of the limbs	GPHN SH3TC2 NCAPD3 LRSAM1 CAPN1 KAT6A AK9 REV3L SLC1A2 LYST ITPR1 NEK1 SBF1 IGHMBP2 PACS2 KIF5A FAR1 DYNC1H1 TBCE	1.64e-05	658	53	19	HP:0009127
MousePheno	induced chromosome breakage	ATR HUS1 FANCA FANCG	5.68e-05	25	120	4	MP:0004030
MousePheno	abnormal apoptosis	HORMAD2 PRAMEF33 ILF3 PRAMEF10 ATR HUS1 ABHD2 BTBD18 BAX ARFGEF1 APEX1 REV3L MED1 FBXO47 CCDC159 FANCA DNAAF2 UNC5A MEI4 PACS2 FAR1 PLK4 DYNC1H1 HTT CDK6 MPI	6.60e-05	1353	120	26	MP:0001648
MousePheno	absent gametes	HORMAD2 PRAMEF33 PRAMEF10 ATR BTBD18 BAX FBXO47 MEI4 SBF1 FAR1	7.06e-05	256	120	10	MP:0001117
MousePheno	abnormal programmed cell death	HORMAD2 PRAMEF33 ILF3 PRAMEF10 ATR HUS1 ABHD2 BTBD18 BAX ARFGEF1 APEX1 REV3L MED1 FBXO47 CCDC159 FANCA DNAAF2 UNC5A MEI4 PACS2 FAR1 PLK4 DYNC1H1 HTT CDK6 MPI	7.19e-05	1360	120	26	MP:0014355
MousePheno	decreased germ cell number	HORMAD2 PRAMEF33 PRAMEF10 ATR CES5A HSPA4L BTBD18 BAX APOB FBXO47 FANCA MEI4 SBF1 TAF7L FAR1 SPAG17 PLK4	7.73e-05	687	120	17	MP:0002209
MousePheno	decreased testis weight	HORMAD2 PRAMEF33 PRAMEF10 ATR BTBD18 BAX FANCA MEI4 FANCG TAF7L FAR1 PLK4	7.98e-05	370	120	12	MP:0004852
MousePheno	abnormal gametogenesis	HORMAD2 PRAMEF33 PRAMEF10 ATR CES5A HSPA4L BTBD18 BAX APOB PKDREJ FBXO47 CCDC159 FANCA MEI4 FANCG NEK1 SBF1 TAF7L FAR1 SPAG17 CDC25B PLK4	1.01e-04	1070	120	22	MP:0001929
MousePheno	spontaneous chromosome breakage	ATR REV3L FANCA FANCG	1.04e-04	29	120	4	MP:0004029
MousePheno	increased apoptosis	PRAMEF33 ILF3 PRAMEF10 ATR HUS1 ABHD2 BTBD18 BAX ARFGEF1 APEX1 REV3L FBXO47 CCDC159 FANCA DNAAF2 MEI4 FAR1 DYNC1H1 HTT CDK6 MPI	1.24e-04	1008	120	21	MP:0006042
MousePheno	increased motor neuron number	GPHN BAX UNC5A	1.28e-04	12	120	3	MP:0005192
MousePheno	abnormal testis weight	HORMAD2 PRAMEF33 PRAMEF10 ATR BTBD18 BAX FANCA MEI4 FANCG TAF7L FAR1 PLK4	1.34e-04	391	120	12	MP:0004850
MousePheno	increased cell death	PRAMEF33 ILF3 PRAMEF10 ATR HUS1 ABHD2 BTBD18 BAX ARFGEF1 APEX1 REV3L FBXO47 CCDC159 FANCA DNAAF2 MEI4 FAR1 DYNC1H1 HTT CDK6 MPI	1.44e-04	1019	120	21	MP:0012556
MousePheno	abnormal cell cycle	HORMAD2 ATR HUS1 BAX MED1 FBXO47 FANCA ESCO2 MEI4 LATS1 CDC25B GCN1 PLK4 DYNC1H1	1.46e-04	520	120	14	MP:0003077
MousePheno	chromosome breakage	ATR HUS1 REV3L FANCA FANCG	1.88e-04	62	120	5	MP:0004028
MousePheno	azoospermia	HORMAD2 PRAMEF33 PRAMEF10 BTBD18 BAX FBXO47 MEI4 SBF1 FAR1	2.52e-04	244	120	9	MP:0005159
MousePheno	abnormal spermatogenesis	HORMAD2 PRAMEF33 PRAMEF10 CES5A HSPA4L BTBD18 BAX APOB PKDREJ FBXO47 CCDC159 FANCA MEI4 FANCG NEK1 SBF1 TAF7L FAR1 SPAG17	2.64e-04	910	120	19	MP:0001156
MousePheno	motor neuron degeneration	GPHN IGHMBP2 DYNC1H1 TBCE	3.04e-04	38	120	4	MP:0000938
MousePheno	abnormal motor neuron morphology	GPHN BAX UNC5A IGHMBP2 KIF5A DYNC1H1 TBCE	3.21e-04	151	120	7	MP:0000937
MousePheno	embryonic lethality between implantation and placentation	NCAPD3 DNAJC13 ATR APEX1 REV3L MED1 PIKFYVE DNAAF2 ZFR ESPL1 DDX24 PLK4 DYNC1H1 HTT	3.43e-04	565	120	14	MP:0009850
MousePheno	decreased male germ cell number	HORMAD2 PRAMEF33 PRAMEF10 CES5A HSPA4L BTBD18 BAX APOB FBXO47 MEI4 SBF1 TAF7L FAR1 SPAG17 PLK4	3.77e-04	640	120	15	MP:0004901
MousePheno	embryonic lethality between implantation and placentation, complete penetrance	NCAPD3 DNAJC13 ATR APEX1 REV3L PIKFYVE DNAAF2 ZFR ESPL1 DDX24 PLK4 DYNC1H1 HTT	4.01e-04	506	120	13	MP:0011095
MousePheno	abnormal germ cell morphology	HORMAD2 PRAMEF33 PRAMEF10 ATR CES5A HSPA4L BTBD18 BAX APOB FBXO47 CCDC159 FANCA MEI4 SBF1 TAF7L FAR1 SPAG17 CDC25B PLK4	4.30e-04	946	120	19	MP:0002208
MousePheno	increased mature ovarian follicle number	ABHD2 BAX	4.34e-04	4	120	2	MP:0008870
MousePheno	hippocampus pyramidal cell degeneration	TRIB2 SLC1A2	4.34e-04	4	120	2	MP:0010014
MousePheno	abnormal foam cell morphology	HORMAD2 PRAMEF33 PRAMEF10 ATR CES5A HSPA4L BTBD18 BAX APOB FBXO47 CCDC159 FANCA MEI4 SBF1 TAF7L FAR1 SPAG17 CDC25B PLK4	4.77e-04	954	120	19	MP:0009840
MousePheno	abnormal mature ovarian follicle morphology	ABHD2 BAX FANCA LATS1 CDK6	5.49e-04	78	120	5	MP:0009364
MousePheno	abnormal ovarian folliculogenesis	ATR ABHD2 BAX FANCA FANCG LATS1	5.82e-04	120	120	6	MP:0001130
MousePheno	abnormal spinal cord morphology	GPHN ATR BAX PIKFYVE UNC5A IGHMBP2 KIF5A DYNC1H1 TBCE	6.52e-04	278	120	9	MP:0000955
Domain	ARM-type_fold	USP34 NCAPD3 DNAJC13 CAND2 ATR RTTN ARFGEF1 APOB BTAF1 HEATR1 LYST ITPR1 FOCAD UPF2 IFRD2 UTP20 GCN1 UNC79 HTT	1.21e-11	339	142	19	IPR016024
Domain	HEAT	NCAPD3 CAND2 ATR BTAF1 HEATR1 UTP20 GCN1 HTT	2.67e-09	48	142	8	PF02985
Domain	HEAT	NCAPD3 CAND2 ATR BTAF1 HEATR1 UTP20 GCN1 HTT	1.27e-08	58	142	8	IPR000357
Domain	HEAT_REPEAT	NCAPD3 CAND2 ATR BTAF1 HEATR1 UTP20 GCN1 HTT	5.81e-08	70	142	8	PS50077
Domain	-	NCAPD3 DNAJC13 CAND2 ATR RTTN ARFGEF1 BTAF1 HEATR1 IFRD2 UTP20 GCN1 HTT	1.32e-07	222	142	12	1.25.10.10
Domain	ARM-like	NCAPD3 DNAJC13 CAND2 ATR RTTN ARFGEF1 BTAF1 HEATR1 TAF7L IFRD2 UTP20 GCN1 HTT	1.50e-07	270	142	13	IPR011989
Pathway	BIOCARTA_ATRBRCA_PATHWAY	ATR HUS1 FANCA FANCG RAD1	2.12e-07	19	104	5	MM1478
Pathway	BIOCARTA_ATRBRCA_PATHWAY	ATR HUS1 FANCA FANCG RAD1	4.73e-07	22	104	5	M9703
Pathway	PID_FANCONI_PATHWAY	ATR HUS1 FANCA FANCG RAD1	2.38e-05	47	104	5	M1
Pathway	WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK	ATR POLM APEX1 REV3L FANCA FANCG GTF2H2	2.92e-05	120	104	7	M40049
Pathway	WP_ATR_SIGNALING	ATR HUS1 RAD1	6.17e-05	11	104	3	M39507
Pathway	KEGG_MEDICUS_REFERENCE_ATR_SIGNALING	ATR HUS1 RAD1	8.18e-05	12	104	3	M47841
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MTA2 USP34 FLII RTTN KAT6A HECTD4 BTAF1 REV3L LYST ZNF503 FANCA FOCAD PIKFYVE SH3PXD2B UBN1 SBF1 IFRD2 NLRC5 ESPL1 GCN1 SMURF2 CRAMP1 DYNC1H1 HTT	6.51e-11	1105	149	24	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	DIP2B FLII NCAPD3 DNAJC13 ILF3 ATR BTAF1 ARHGAP39 MED1 EIF2D LATS1 UBN1 FAM13A SVIL ZBTB21 PACS2 UTP20 ESPL1 DDX24	1.04e-09	774	149	19	15302935
Pubmed	Defining the membrane proteome of NK cells.	MTA2 DIP2B NCAPD3 DNAJC13 ILF3 BAX DGKA LRRC59 HEATR1 MED1 ANKRD27 TUFM ITPR1 CEP350 MED15 PIGT FAM120A IGHMBP2 KIF5A DDX24 GCN1 DYNC1H1	6.02e-09	1168	149	22	19946888
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MTA2 FLII DNAJC13 ILF3 LRSAM1 CAPN1 EXOSC3 HEATR1 ANKRD27 TUFM ASAP1 EIF2D FAM120A UBN1 SBF1 UPF2 RPF2 UTP20 ZFR FAR1 DDX24 GCN1 DYNC1H1	1.76e-08	1353	149	23	29467282
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	MTA2 GPHN ILF3 LRRC59 HEATR1 MED1 TUFM ASAP1 ESCO2 DNAAF2 SH3PXD2B RPF2 CRYBG3 HDGFL2	1.82e-08	472	149	14	38943005
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	FLII NCAPD3 DNAJC13 ATR BTAF1 MED1 TUFM SBF1 UTP20 GCN1	1.89e-08	202	149	10	33005030
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DIP2B NCAPD3 ATR DGKA BTAF1 ANKRD27 DENND3 TUFM ITPR1 FANCA EIF2D FAM120A SBF1 UPF2 CRYBG3 CDC25B	2.27e-08	650	149	16	38777146
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MTA2 FLII NCAPD3 DNAJC13 KAT6A EXOSC3 HEATR1 MED1 FAM120A UPF2 IGHMBP2 UTP20 ZFR FAR1 ESPL1 DDX24 GCN1	3.18e-08	759	149	17	35915203
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GPHN DIP2B ARHGEF17 LYST ANKRD27 CEP350 NEK1 SH3PXD2B LATS1 FAM13A SBF1 SVIL ZBTB21 MIEF1 CRYBG3 CDC25B PLK4 DOP1A	3.46e-08	861	149	18	36931259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPHN DIP2B FLII DLGAP1 DNAJC13 ILF3 NHSL2 HECTD4 ARHGAP39 SLC1A2 SH3PXD2B FAM120A SBF1 SVIL ZBTB21 ZFR KIF5A UNC79 DYNC1H1	3.48e-08	963	149	19	28671696
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	USP34 DNAJC13 BTBD18 EXOSC3 MUC16 APEX1 APOB BTAF1 TUFM SBF1 ZFR CDC25B DOP1A	3.66e-08	420	149	13	28065597
Pubmed	ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function.	ATR FANCA FANCG	7.71e-08	3	149	3	19109555
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	FLII DNAJC13 ILF3 CAPN1 EXOSC3 LRRC59 MED1 CEP350 SH3PXD2B FAM120A SBF1 UPF2 ZFR ESPL1 DDX24 GCN1	9.93e-08	724	149	16	36232890
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MTA2 DIP2B DNAJC13 ILF3 HECTD4 APEX1 LRRC59 ARHGAP39 MED1 TUFM TRMT10C SBF1 UPF2 RPF2 USP12 ALB DDX24 GCN1 DYNC1H1	2.11e-07	1082	149	19	38697112
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MTA2 GPHN FLII DLGAP1 DNAJC13 ILF3 HSPA4L LRRC59 ARHGAP39 ARHGEF17 SLC1A2 TUFM ASAP1 FAM120A SBF1 UPF2 SVIL PLXNA4 PACS2 ALB PLPPR2 DYNC1H1	2.12e-07	1431	149	22	37142655
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MTA2 USP34 NCAPD3 CAND2 HSPA4L EXOSC3 LRRC59 BTAF1 HEATR1 COG3 TUFM ITPR1 TRMT10C PIGT FAM120A UBN1 RPF2 ZFR FAR1 DDX24 GCN1 DYNC1H1	2.36e-07	1440	149	22	30833792
Pubmed	Nucleolar proteome dynamics.	NCAPD3 ILF3 ATR APEX1 TUFM GTF2H2 RPF2 UTP20 ZFR DDX24 GCN1 DYNC1H1	2.87e-07	419	149	12	15635413
Pubmed	Differential Dynamics of ATR-Mediated Checkpoint Regulators.	ATR HUS1 RAD1	3.07e-07	4	149	3	20847938
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	NCAPD3 ARFGEF1 BTAF1 ITPR1 FANCA FAR1 HTT	3.45e-07	104	149	7	31240132
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	FLII NCAPD3 ILF3 CAND2 CAPN1 EXOSC3 HEATR1 TUFM UPF2 UTP20 ZFR DDX24 GCN1 DYNC1H1 CDK6	4.05e-07	704	149	15	29955894
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DIP2B DNAJC13 ABHD2 CAPN1 KAT6A HECTD4 EXOSC3 BTAF1 ARHGAP39 COG3 SEC22A TASOR2 CCNG2 GTF2H2 FAM120A FAM13A RPF2 NLRC5 SMURF2 CRAMP1 HTT DOP1A	4.15e-07	1489	149	22	28611215
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MTA2 GPHN HEATR1 MED1 TUFM MED15 NEK1 SH3PXD2B LATS1 ZFR GCN1 DYNC1H1 HTT	7.78e-07	549	149	13	38280479
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MTA2 USP34 CAPN1 HEATR1 TUFM TASOR2 FAM120A SBF1 RPF2 UTP20 ZFR DDX24 GCN1 DYNC1H1	9.35e-07	653	149	14	22586326
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	MTA2 GPHN USP34 DIP2B NCAPD3 CAND2 HSPA4L NAP1L5 HEATR1 TRMT10C FAM120A SBF1 KIF5A FAR1 CDC25B ESPL1 GCN1	1.05e-06	974	149	17	28675297
Pubmed	Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.	KIF5A DYNC1H1 HTT	1.53e-06	6	149	3	19525941
Pubmed	SIRT6 protein deacetylase interacts with MYH DNA glycosylase, APE1 endonuclease, and Rad9-Rad1-Hus1 checkpoint clamp.	HUS1 APEX1 RAD1	1.53e-06	6	149	3	26063178
Pubmed	Inactivation of mouse Hus1 results in genomic instability and impaired responses to genotoxic stress.	HUS1 BAX RAD1	1.53e-06	6	149	3	10921903
Pubmed	Knockdown of mu-calpain in Fanconi anemia, FA-A, cells by siRNA restores alphaII spectrin levels and corrects chromosomal instability and defective DNA interstrand cross-link repair.	CAPN1 FANCA FANCG	1.53e-06	6	149	3	20518497
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	MTA2 FLII ILF3 CAPN1 EXOSC3 LRRC59 HEATR1 TUFM TASOR2 TRMT10C FAM120A UPF2 SVIL RPF2 UTP20 ZFR ALB DDX24 DYNC1H1	1.98e-06	1257	149	19	36526897
Pubmed	Charcot-Marie-Tooth Hereditary Neuropathy Overview	SH3TC2 LRSAM1 SBF1 IGHMBP2 DYNC1H1	1.99e-06	48	149	5	20301532
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MTA2 FLII ILF3 LRRC59 BTAF1 HEATR1 TUFM CEP350 SVIL RPF2 ZBTB21 UTP20 ZFR ALB FAR1 GCN1 DYNC1H1	2.07e-06	1024	149	17	24711643
Pubmed	Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.	ATR HUS1 MED1 FANCA FANCG RAD1	2.42e-06	89	149	6	18950845
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MTA2 FLII NCAPD3 ILF3 ATR HSPA4L APOB LRRC59 HEATR1 TUFM TRMT10C FAM120A RPF2 UTP20 ZFR KIF3C FAR1 DDX24 GCN1 DYNC1H1	3.19e-06	1425	149	20	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ILF3 HSPA4L NHSL2 DGKA APOB LRRC59 HEATR1 LYST TUFM TASOR2 LATS1 RPF2 ZBTB21 PLXNA4 ZFR KIF5A SPAG17 HDGFL2 SMURF2 DOP1A	3.81e-06	1442	149	20	35575683
Pubmed	ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.	ATR HUS1 RAD1	4.25e-06	8	149	3	18162465
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	USP34 NCAPD3 ILF3 ATR HUS1 MED1 FANCA MED15 FANCG RAD1 ZFR	4.47e-06	453	149	11	29656893
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	DIP2B FLII ILF3 HSPA4L BAX LRRC59 HEATR1 RMDN2 TUFM ITPR1 PIKFYVE TRMT10C FAM120A UPF2 RPF2 MIEF1 ZFR CRYBG3 ESPL1 DDX24	6.57e-06	1496	149	20	32877691
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	MTA2 FLII ILF3 KBTBD8 APOB LRRC59 MED1 TUFM ESCO2 CEP350 TRMT10C GTF2H2 FAM120A UPF2 SVIL USP12 MIEF1 GCN1 DYNC1H1	6.88e-06	1371	149	19	36244648
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP34 DNAJC13 BAX ARFGEF1 MUC16 APOB TUFM TASOR2 CEP350 MIEF1 ZFR ALB GCN1 DYNC1H1	6.93e-06	777	149	14	35844135
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	FLII ILF3 HSPA4L CAPN1 BAX APEX1 LRRC59 MED1 TUFM MED15 EIF2D LATS1 FAM120A IGHMBP2 SVIL DDX24 GCN1 DYNC1H1	7.07e-06	1247	149	18	27684187
Pubmed	A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.	USP34 ATR MED1	9.05e-06	10	149	3	17478428
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	HUS1 HSPA4L NAP1L5 LRRC59 HEATR1 TUFM EIF2D KLHDC3 RPF2 ZBTB21 FAR1 CDC25B DDX24 GCN1 UNC79 HDGFL2 DYNC1H1 CDK6	1.05e-05	1284	149	18	17353931
Pubmed	Activator-Mediator binding regulates Mediator-cofactor interactions.	MED1 MED15 GCN1	1.24e-05	11	149	3	20534441
Pubmed	Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.	NLRP11 ATR BAX REV3L ESCO2 RAD1 CDK6	1.29e-05	179	149	7	19074885
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	NCAPD3 CAND2 HSPA4L BAX ARFGEF1 LRRC59 BTAF1 HEATR1 TUFM FANCA UTP20 FAR1 ESPL1 GCN1 DYNC1H1	1.39e-05	942	149	15	31073040
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	MTA2 ILF3 HSPA4L LRRC59 HEATR1 ANKRD27 TUFM TRMT10C GTF2H2 FAM120A UPF2 IFRD2 RPF2 ALB FAR1 DDX24 GCN1 DYNC1H1	1.49e-05	1318	149	18	30463901
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MTA2 GPHN DNAJC13 CAND2 HEATR1 MED1 MED15 EFHC2 DNAAF2 NEK1 PIGT ZBTB21 KIF3C CDC25B DDX24 GCN1 DYNC1H1 TBCE	1.53e-05	1321	149	18	27173435
Pubmed	ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.	MTA2 FLII HEATR1 TUFM TASOR2 FANCG EIF2D GTF2H2 ZFR ALB FAR1 DDX24	1.71e-05	624	149	12	33729478
Pubmed	A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.	FLII NCAPD3 DDX24 GCN1 DYNC1H1 CDK6	1.72e-05	125	149	6	21654808
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 PRAMEF33 PRAMEF10 CAND2 ABHD2 KBTBD8 DGKA APOB HEATR1 ASAP1 ITPR1 ESCO2 SH3PXD2B KLHDC3 ESPL1 CDK6	1.80e-05	1084	149	16	11544199
Pubmed	A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA.	FANCA FANCG	1.82e-05	2	149	2	11739169
Pubmed	Regulation of the glutamate transporter EAAT2 by PIKfyve.	SLC1A2 PIKFYVE	1.82e-05	2	149	2	19910676
Pubmed	The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex.	FANCA FANCG	1.82e-05	2	149	2	11050007
Pubmed	Functional analysis of the putative peroxidase domain of FANCA, the Fanconi anemia complementation group A protein.	FANCA FANCG	1.82e-05	2	149	2	11161829
Pubmed	Fanca deficiency reduces A/T transitions in somatic hypermutation and alters class switch recombination junctions in mouse B cells.	FANCA FANCG	1.82e-05	2	149	2	24799500
Pubmed	Clinical and Genetic Features of Patients With Fanconi Anemia in Lebanon and Report on Novel Mutations in the FANCA and FANCG Genes.	FANCA FANCG	1.82e-05	2	149	2	32947577
Pubmed	FANCA Promotes DNA Double-Strand Break Repair by Catalyzing Single-Strand Annealing and Strand Exchange.	FANCA FANCG	1.82e-05	2	149	2	30057198
Pubmed	Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.	FANCA FANCG	1.82e-05	2	149	2	15192709
Pubmed	Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.	FANCA FANCG	1.82e-05	2	149	2	22036606
Pubmed	Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg.	FANCA FANCG	1.82e-05	2	149	2	11918676
Pubmed	Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.	ATR REV3L	1.82e-05	2	149	2	28075014
Pubmed	Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.	CAPN1 HTT	1.82e-05	2	149	2	19036965
Pubmed	Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins.	FANCA FANCG	1.82e-05	2	149	2	15138265
Pubmed	Deubiquitinating Enzyme USP12 Regulates the Pro-Apoptosis Protein Bax.	BAX USP12	1.82e-05	2	149	2	36361894
Pubmed	Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis.	FANCA FANCG	1.82e-05	2	149	2	10652215
Pubmed	Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain.	FANCA FANCG	1.82e-05	2	149	2	10567393
Pubmed	Novel mutations of the FANCG gene causing alternative splicing in Japanese Fanconi anemia.	FANCA FANCG	1.82e-05	2	149	2	10807541
Pubmed	Multiple TPR motifs characterize the Fanconi anemia FANCG protein.	FANCA FANCG	1.82e-05	2	149	2	14697762
Pubmed	FANCA and FANCG are the major Fanconi anemia genes in the Korean population.	FANCA FANCG	1.82e-05	2	149	2	23067021
Pubmed	Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.	SLC1A2 HTT	1.82e-05	2	149	2	12135980
Pubmed	Necessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility.	CAPN1 ITPR1	1.82e-05	2	149	2	17690304
Pubmed	A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.	FANCA FANCG	1.82e-05	2	149	2	10468606
Pubmed	Rare germinal unequal crossing-over leading to recombinant gene formation and gene duplication in Arabidopsis thaliana.	FANCA FANCG	1.82e-05	2	149	2	10468603
Pubmed	Human hRad1 but not hRad9 protects hHus1 from ubiquitin-proteasomal degradation.	HUS1 RAD1	1.82e-05	2	149	2	15122316
Pubmed	Bax and calpain mediate excitotoxic oligodendrocyte death induced by activation of both AMPA and kainate receptors.	CAPN1 BAX	1.82e-05	2	149	2	21414921
Pubmed	Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs.	FANCA FANCG	1.82e-05	2	149	2	15059067
Pubmed	Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment.	FANCA FANCG	1.82e-05	2	149	2	11181053
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	EXOSC3 DGKA REV3L ARHGEF17 TUFM FANCA FOCAD RANBP3L PLXNA4 UTP20 ALB DYNC1H1 FBXO34	1.84e-05	736	149	13	29676528
Pubmed	A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling.	ATR HUS1 RAD1	2.14e-05	13	149	3	21659603
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	GPHN FLII CAPN1 EXOSC3 HEATR1 ZNF503 CEP350 PIGT LATS1 IGHMBP2 UTP20 ZFR GCN1	2.37e-05	754	149	13	33060197
Pubmed	Identification of host proteins required for HIV infection through a functional genomic screen.	FLII DLGAP1 EXOSC3 HEATR1 COG3 EFHC2 IGHMBP2 KIF3C	2.43e-05	272	149	8	18187620
Pubmed	Genetic and physical delineation of the region overlapping the progressive motor neuropathy (pmn) locus on mouse chromosome 13.	HEATR1 LYST TBCE	2.71e-05	14	149	3	11472062
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	MTA2 ILF3 LRRC59 TUFM ASAP1 FAM120A KLHDC3 RPF2 UTP20 ZFR DDX24 GCN1	2.74e-05	655	149	12	35819319
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	NCAPD3 DNAJC13 ILF3 HEATR1 UPF2 RPF2 GCN1	2.81e-05	202	149	7	24639526
Pubmed	Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.	POLM APEX1 REV3L FANCA FANCG	3.17e-05	84	149	5	19237606
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	ATR HSPA4L BTAF1 FAM120A UTP20 ZFR GCN1 HTT	3.38e-05	285	149	8	32838362
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	DIP2B DLGAP1 ARHGAP39 PIKFYVE SH3PXD2B LATS1 FAR1	4.56e-05	218	149	7	33378226
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	NCAPD3 ILF3 LRRC59 TUFM SH3PXD2B UPF2 IGHMBP2 RPF2 FAR1 DDX24	5.01e-05	486	149	10	30940648
Pubmed	Identification of RanBP 9/10 as interacting partners for protein kinase C (PKC) gamma/delta and the D1 dopamine receptor: regulation of PKC-mediated receptor phosphorylation.	ITPR1 ART3 DYNC1H1	5.01e-05	17	149	3	20395553
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	MTA2 DIP2B MED1 TUFM ITPR1 MED15 EIF2D GTF2H2 FAM120A RPF2 ALB GCN1	5.27e-05	701	149	12	30196744
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	MTA2 GPHN USP34 FLII HSPA4L LRSAM1 CAPN1 NAP1L5 APEX1 XPNPEP1 COG3 TUFM ZNF503 GCN1 HDGFL2 DYNC1H1 HTT TBCE	5.42e-05	1455	149	18	22863883
Pubmed	Crystal structure of the human rad9-hus1-rad1 clamp.	HUS1 RAD1	5.45e-05	3	149	2	19464297
Pubmed	Phosphorylation of fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway.	FANCA FANCG	5.45e-05	3	149	2	15299017
Pubmed	Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.	FANCA FANCG	5.45e-05	3	149	2	12135664
Pubmed	Iron induces B cell pyroptosis through Tom20-Bax-caspase-gasdermin E signaling to promote inflammation post-spinal cord injury.	BAX GSDME	5.45e-05	3	149	2	37480037
Pubmed	Reconstitution and molecular analysis of the hRad9-hHus1-hRad1 (9-1-1) DNA damage responsive checkpoint complex.	HUS1 RAD1	5.45e-05	3	149	2	11340080
Pubmed	Physical interactions among human checkpoint control proteins HUS1p, RAD1p, and RAD9p, and implications for the regulation of cell cycle progression.	HUS1 RAD1	5.45e-05	3	149	2	10777662
Pubmed	The Rad9 protein enhances survival and promotes DNA repair following exposure to ionizing radiation.	HUS1 RAD1	5.45e-05	3	149	2	16814252
Pubmed	Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity.	FANCA FANCG	5.45e-05	3	149	2	10961856
Pubmed	Tri-cistronic cloning, overexpression and purification of human Rad9, Rad1, Hus1 protein complex.	HUS1 RAD1	5.45e-05	3	149	2	17493829
Interaction	SCN2B interactions	CAND2 ATR HUS1 SPPL3 HEATR1 COG3 FOCAD GSDME UTP20 GCN1	1.63e-09	95	145	10	int:SCN2B
Interaction	NPTN interactions	CAND2 ATR ARFGEF1 BTAF1 HEATR1 COG3 FANCA FOCAD PIKFYVE FANCG UTP20 GCN1 HTT DOP1A	1.42e-08	278	145	14	int:NPTN
Interaction	YWHAH interactions	DIP2B DLGAP1 ILF3 NHSL2 HECTD4 SPPL3 MED1 ARHGEF17 LYST ANKRD27 CEP350 NEK1 SH3PXD2B LATS1 FAM13A SBF1 SVIL ZBTB21 USP12 MIEF1 PACS2 KIF5A CRYBG3 CDC25B PLK4 HTT DOP1A	1.92e-08	1102	145	27	int:YWHAH
Interaction	YWHAQ interactions	DLGAP1 ILF3 HUS1 CAPN1 HECTD4 BAX MED1 LYST CEP350 NEK1 LATS1 FAM13A SBF1 SVIL ZBTB21 MIEF1 PACS2 ALB KIF5A CDC25B DDX24 GCN1 UNC79 PLK4 DYNC1H1 HTT DOP1A	2.59e-08	1118	145	27	int:YWHAQ
Interaction	TOP3B interactions	MTA2 USP34 FLII RTTN KAT6A HECTD4 APOB BTAF1 REV3L LYST TUFM ZNF503 FANCA FOCAD PIKFYVE SH3PXD2B FAM120A UBN1 SBF1 UPF2 SVIL IFRD2 NLRC5 ZFR ESPL1 GCN1 SMURF2 CRAMP1 DYNC1H1 HTT	1.62e-07	1470	145	30	int:TOP3B
Interaction	OPALIN interactions	NCAPD3 CAND2 ATR RTTN ARFGEF1 BTAF1 HEATR1 SBF1 USP12 UTP20 GCN1	3.45e-07	209	145	11	int:OPALIN
Interaction	NPY2R interactions	CAND2 ARFGEF1 APEX1 BTAF1 FANCA GCN1 HTT	4.71e-07	66	145	7	int:NPY2R
Interaction	YWHAB interactions	DLGAP1 NCAPD3 KAT6A HECTD4 BAX RMDN2 ARHGEF17 LYST CEP350 NEK1 LATS1 FAM13A SVIL ZBTB21 USP12 MIEF1 PACS2 KIF5A CDC25B DDX24 PLK4 DYNC1H1 HTT	9.59e-07	1014	145	23	int:YWHAB
Interaction	GPR17 interactions	CAND2 ATR SPPL3 ARFGEF1 BTAF1 HEATR1 COG3 FANCA FANCG UTP20 HTT DOP1A	1.00e-06	283	145	12	int:GPR17
Interaction	LRRC31 interactions	FLII NCAPD3 DNAJC13 ATR BTAF1 MED1 TUFM SBF1 UTP20 GCN1	2.38e-06	205	145	10	int:LRRC31
Interaction	SFN interactions	BAX LRRC59 ARHGEF17 LYST CEP350 PIGT LATS1 FAM13A SVIL ZBTB21 MIEF1 PACS2 CRYBG3 CDC25B DDX24 PLK4 HTT DOP1A	2.51e-06	692	145	18	int:SFN
Interaction	CTDP1 interactions	NCAPD3 ARFGEF1 APEX1 BTAF1 MED1 ITPR1 FANCA MED15 FAR1 HTT	2.60e-06	207	145	10	int:CTDP1
Interaction	BCL2L14 interactions	MTA2 NCAPD3 CAND2 BAX HEATR1 TUFM GCN1 HDGFL2	3.85e-06	127	145	8	int:BCL2L14
Interaction	GPR182 interactions	NCAPD3 CAND2 ATR SPPL3 ARFGEF1 BTAF1 HEATR1 COG3 FANCA FOCAD FANCG UTP20 GCN1 HTT	5.40e-06	455	145	14	int:GPR182
Interaction	SPTAN1 interactions	GPHN DLGAP1 NCAPD3 CAPN1 APOB FANCA FANCG GSDME LATS1 FAM120A SVIL ALB DDX24 HTT	1.43e-05	496	145	14	int:SPTAN1
Interaction	CCDC8 interactions	FLII ILF3 APOB LRRC59 BTAF1 HEATR1 TUFM CEP350 SVIL ZBTB21 UTP20 ZFR ALB FAR1 GCN1 DYNC1H1	2.08e-05	656	145	16	int:CCDC8
Interaction	YWHAG interactions	GPHN DLGAP1 NHSL2 HECTD4 ARHGEF17 LYST CEP350 NEK1 LATS1 FAM13A SBF1 SVIL ZBTB21 USP12 MIEF1 PACS2 ALB KIF5A CDC25B PLK4 DYNC1H1 HTT DOP1A	2.90e-05	1248	145	23	int:YWHAG
Interaction	FAAP24 interactions	ATR APEX1 FANCA FANCG	3.40e-05	26	145	4	int:FAAP24
Interaction	GPR45 interactions	NCAPD3 ATR SPPL3 ARFGEF1 BTAF1 HEATR1 COG3 FANCA GSDME GCN1	6.46e-05	300	145	10	int:GPR45
Interaction	YWHAZ interactions	DLGAP1 NCAPD3 KAT6A HECTD4 LYST ANKRD27 TUFM ITPR1 NEK1 LATS1 FAM13A SBF1 SVIL ZBTB21 MIEF1 PACS2 KIF5A CDC25B DDX24 PLK4 DYNC1H1 HTT SENP7	6.79e-05	1319	145	23	int:YWHAZ
Interaction	MUTYH interactions	ATR HUS1 LRSAM1 APEX1	6.95e-05	31	145	4	int:MUTYH
Interaction	OPRM1 interactions	ATR SPPL3 COG3 SEC22A FANCA GCN1 HTT	8.34e-05	144	145	7	int:OPRM1
Interaction	RAD9B interactions	HUS1 APEX1 RAD1	9.90e-05	13	145	3	int:RAD9B
Interaction	COMTD1 interactions	NCAPD3 APEX1 BTAF1 HEATR1 COG3 GSDME UPF2 GCN1	1.02e-04	200	145	8	int:COMTD1
Interaction	P2RY10 interactions	CAND2 SPPL3 HEATR1 COG3 FANCA MPI	1.18e-04	106	145	6	int:P2RY10
Interaction	CD6 interactions	DIP2B NCAPD3 KBTBD8 XPNPEP1 GTF2H2 SBF1 USP12	1.27e-04	154	145	7	int:CD6
Interaction	TP53BP1 interactions	MTA2 USP34 ILF3 ATR HUS1 SPPL3 APEX1 MED1 MED15 NEK1 RAD1 ZFR SMURF2	1.29e-04	533	145	13	int:TP53BP1
Interaction	BTNL9 interactions	USP34 NCAPD3 CAND2 BTAF1 FOCAD GSDME SBF1	1.38e-04	156	145	7	int:BTNL9
Interaction	MEN1 interactions	MTA2 NCAPD3 DNAJC13 ILF3 EXOSC3 ARFGEF1 APEX1 BTAF1 HEATR1 MED1 ARHGEF17 FANCA FAM120A UPF2 RPF2 UTP20 ZFR FAR1 DDX24	1.50e-04	1029	145	19	int:MEN1
Interaction	SIRT6 interactions	MTA2 ILF3 HUS1 HSPA4L HECTD4 EXOSC3 APEX1 MED1 TASOR2 ITPR1 FANCA SBF1 RAD1 ESPL1	1.80e-04	628	145	14	int:SIRT6
GeneFamily	Checkpoint clamp complex	HUS1 RAD1	7.00e-05	3	88	2	1339
GeneFamily	Gelsolin/villins	FLII SVIL	6.43e-04	8	88	2	950
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	USP34 DNAJC13 ATR KAT6A ARFGEF1 BTAF1 REV3L MED1 ITPR1 CEP350 PIKFYVE NEK1 UPF2 USP12 UTP20 CRYBG3 SMURF2 FOXD1	1.90e-06	856	149	18	M4500
Coexpression	PATIL_LIVER_CANCER	ILF3 CAPN1 ARFGEF1 ARHGAP39 ANKRD27 ASAP1 ESCO2 FANCG SH3PXD2B RAD1 CDC25B ESPL1 PLK4 DYNC1H1 TBCE	5.76e-06	660	149	15	M1195
Coexpression	PUJANA_BRCA2_PCC_NETWORK	ILF3 ATR BAX BTAF1 FANCA PIKFYVE FANCG GTF2H2 RAD1 CDC25B ESPL1 PLK4	6.22e-06	426	149	12	M9516
Coexpression	SAGIV_CD24_TARGETS_UP	USP34 DNAJC13 ARFGEF1 PLPPR2	6.77e-06	22	149	4	M4144
Coexpression	KAUFFMANN_DNA_REPAIR_GENES	ATR HUS1 POLM APEX1 REV3L FANCA FANCG GTF2H2 RAD1	7.10e-06	230	149	9	M11563
Coexpression	BROWNE_HCMV_INFECTION_14HR_DN	CAND2 BAX REV3L ARHGEF17 DENND3 NEK1 ZFR CDC25B MPI	4.43e-05	290	149	9	M13251
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000	HORMAD2 LYST FBXO47 TASOR2 PIKFYVE NEK1 TAF7L HTT DOP1A	5.69e-06	187	145	9	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP34 DIP2B ATR MED1 TASOR2 CEP350 LATS1 FAM120A CRYBG3 DYNC1H1	1.09e-09	193	149	10	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	POLM DGKA NEK1 IGHMBP2 MIEF1 NLRC5 KIF3C CDC25B	1.11e-07	170	149	8	070d8683d1a5cc7d594ff0453c961a9bf982c2d0
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma\|TCGA-Kidney / Sample_Type by Project: Shred V9	FLII DLGAP1 ARHGAP40 CAPN1 ARHGAP39 TUFM IFRD2	3.04e-06	185	149	7	46f4f6f20b1e152922f6f2ba1244c56e48a49b79
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 ARFGEF1 BTAF1 TASOR2 ITPR1 FAM13A DYNC1H1	3.38e-06	188	149	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Control-Neu_4\|Control / 5 Neutrophil clusters in COVID-19 patients	APEX1 XPNPEP1 HEATR1 TUFM ARSD HTT CDK6	4.45e-06	196	149	7	b8b7b54ca17a08fa775507bb22b1c7248ada8f40
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NHSL2 CAPN1 TMC4 LYST FANCA C5AR1	1.91e-05	164	149	6	8e6dbddacd56a07769163813e3ebfad13302bb62
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXD2 CAND2 PIKFYVE EIF2D PLK4 TBCE	2.58e-05	173	149	6	12f779b8dce79431b2d1002ba524dd3f9566aeb0
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIGD1B LRRC9 ESCO2 ART3 CDC25B PLK4	2.75e-05	175	149	6	15c69dd5635c9251c535f1e22467712e9667ae92
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPD3 NHSL2 FANCA ESCO2 GSDME PLK4	3.33e-05	181	149	6	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPD3 NHSL2 FANCA ESCO2 GSDME PLK4	3.33e-05	181	149	6	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	ABHD2 XPNPEP1 MED15 ARSD HDGFL2 HTT	3.65e-05	184	149	6	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	15-Trachea-Epithelial-Multiciliated_precursor\|Trachea / Age, Tissue, Lineage and Cell class	HSPA4L RTTN CEP350 ZBTB21 SPAG17 PLK4	3.76e-05	185	149	6	9a8b8360d99375b726ca8e3c9a3f9b08919892d7
ToppCell	368C-Lymphocytic-NK_cells-Proliferating_NK_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	DENND3 FANCA ESCO2 RAD1 CRAMP1 FBXO34	4.23e-05	189	149	6	31d34bc75d4457fca197e1766922e987dbd5f8a9
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FMO4 LRSAM1 NAP1L5 AK9 DYNC1H1 HTT	4.49e-05	191	149	6	cadb7a9de16f4bb21606de0e25cddd2d748c7f0b
ToppCell	Immune_cells-small_pre-B.\|Immune_cells / Lineage and Cell class	NCAPD3 TRIB2 POLM ESCO2 CCNG2 CDC25B	4.90e-05	194	149	6	6a440c09805110b1e48e5959a3a9e094c6716bfb
ToppCell	severe_influenza-T/NK_proliferative\|severe_influenza / disease group, cell group and cell class (v2)	NCAPD3 ESCO2 FANCG CDC25B ESPL1 PLK4	5.64e-05	199	149	6	638b1491c47f2884daf1c1d38a779ad8e0f59c52
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 RTTN ARFGEF1 BTAF1 NLRC5 DDX24	5.64e-05	199	149	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	severe_influenza-T/NK_proliferative\|World / disease group, cell group and cell class (v2)	NCAPD3 ESCO2 FANCG CDC25B ESPL1 PLK4	5.64e-05	199	149	6	1541f655f7d12c650added3683d07e5417a68dfb
ToppCell	Frontal_cortex-Neuronal\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	USP34 DLGAP1 HECTD4 ZFR KIF5A DDX24	5.64e-05	199	149	6	f88039d862f3bfa01dc39d2de4f3f548dc5a0e61
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma\|TCGA-Liver / Sample_Type by Project: Shred V9	POLM EIF2D PIGT HDGFL2 PLPPR2 TBCE	5.80e-05	200	149	6	9cff8be6e566f342fc8b45e93106d033b14759ee
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Mild / Disease, condition lineage and cell class	NCAPD3 FANCA ESCO2 FANCG ESPL1 PLK4	5.80e-05	200	149	6	6126a3bbafe2110fba0c1c4493035df4e8193d22
ToppCell	TCGA-Liver-Primary_Tumor\|TCGA-Liver / Sample_Type by Project: Shred V9	POLM EIF2D PIGT HDGFL2 PLPPR2 TBCE	5.80e-05	200	149	6	b667168081393433597f6ca8baeddba1d1906d40
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-T/NK_proliferative\|Influenza_Severe / Disease, condition lineage and cell class	TMEM121 ESCO2 FANCG CDC25B ESPL1 PLK4	5.80e-05	200	149	6	e1c266525ce6b42a4451b6a3b0cabf41ff5e2ee7
Drug	naringenin	BAX APOB MED1 LYST MED15 PIKFYVE GSDME KLHDC3	3.08e-06	136	148	8	CID000000932
Drug	Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; HL60; HT_HG-U133A	USP34 ABHD2 BAX LYST ASAP1 NEK1 KLHDC3 PLK4 CDK6	4.99e-06	193	148	9	1269_UP
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	USP34 ABHD2 ARFGEF1 PIKFYVE CCNG2 NEK1 PIGT PLK4 TBCE	5.42e-06	195	148	9	7444_DN
Disease	Charcot-Marie-Tooth disease	SH3TC2 SBF1 IGHMBP2 DYNC1H1	4.86e-05	42	141	4	cv:C0007959
Disease	Growth retardation, pre- and postnatal	FANCA FANCG	6.78e-05	3	141	2	C2750866
Disease	ovarian cancer (is_implicated_in)	MUC16 APEX1 APOB FANCA	1.51e-04	56	141	4	DOID:2394 (is_implicated_in)
Disease	Large cell carcinoma of lung	ATR NEK1 LATS1	4.79e-04	32	141	3	C0345958
Disease	level of Phosphatidylinositol (16:0_18:2) in blood serum	TMC4 RMDN2	6.23e-04	8	141	2	OBA_2045153
Disease	tumor necrosis factor receptor superfamily member 19L measurement	ARHGEF17 PIKFYVE	6.23e-04	8	141	2	EFO_0008309
Disease	neurodegenerative disease (implicated_via_orthology)	SLC1A2 LATS1 KIF5A DYNC1H1 HTT	6.76e-04	145	141	5	DOID:1289 (implicated_via_orthology)
Disease	cysteine measurement	FMO4 TTL	7.98e-04	9	141	2	EFO_0021000
Disease	IgG bisecting N-acetyl glucosamine measurement	TMEM121 KIF3C	7.98e-04	9	141	2	EFO_0008426
Disease	Fanconi anemia (is_implicated_in)	FANCA FANCG	9.95e-04	10	141	2	DOID:13636 (is_implicated_in)
Disease	cytochrome p450 3a4 measurement	APOB PIKFYVE	1.21e-03	11	141	2	EFO_0020303
Disease	hearing impairment	FANCA FANCG SH3PXD2B GSDME	1.27e-03	98	141	4	C1384666
Disease	high density lipoprotein particle size measurement	APOB INTS10 PIGT FAM13A NLRC5	1.38e-03	170	141	5	EFO_0008592
Disease	Alzheimer's disease (is_marker_for)	ATR CAPN1 BAX ITPR1 C5AR1 DYNC1H1	1.52e-03	257	141	6	DOID:10652 (is_marker_for)
Disease	reticulocyte measurement	GPHN USP34 ATR HSPA4L KBTBD8 HECTD4 SPPL3 DENND3 PIKFYVE RANBP3L IFRD2 HDGFL2 FBXO34	1.66e-03	1053	141	13	EFO_0010700
Disease	Charcot-Marie-Tooth disease type 4	SH3TC2 SBF1	1.71e-03	13	141	2	cv:C4082197
Disease	myeloid white cell count	USP34 DNAJC13 TRIB2 HECTD4 SPPL3 FAM13A NLRC5 KIF3C SPAG17 FBXO34 HTT CDK6	1.85e-03	937	141	12	EFO_0007988
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	TRIB2 FANCA UBN1 FAM13A UNC79 HTT SENP7	1.89e-03	364	141	7	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Fanconi anemia	FANCA FANCG	1.99e-03	14	141	2	cv:C0015625
Disease	platelet crit	DIP2B TRIB2 NHSL2 RTTN BAX APOB TMC4 FBXO47 SVIL HDGFL2 SENP7 CDK6	2.11e-03	952	141	12	EFO_0007985
Disease	FEV/FEC ratio	USP34 CES5A ARHGEF17 SLC1A2 DENND3 ASAP1 ITPR1 MED15 CCNG2 FAM13A SVIL C5AR1 PLPPR2 SMURF2	2.31e-03	1228	141	14	EFO_0004713
Disease	cholesterol to total lipids in large HDL percentage	APOB INTS10 FAM13A	2.34e-03	55	141	3	EFO_0022234
Disease	triglycerides to total lipids in medium HDL percentage	APOB INTS10 NLRC5	2.46e-03	56	141	3	EFO_0022333
Disease	cholesteryl esters to total lipids in medium HDL percentage	APOB INTS10 NLRC5	2.46e-03	56	141	3	EFO_0022251
Disease	body fat percentage	TRIB2 TUFM FANCA UBN1 FAM13A UNC79 HTT SENP7	2.47e-03	488	141	8	EFO_0007800
Disease	mean corpuscular hemoglobin concentration	DNAJC13 ATR HSPA4L LRSAM1 RTTN HECTD4 XPNPEP1 FOCAD FANCG KIF3C HDGFL2 PLK4 SENP7	2.52e-03	1105	141	13	EFO_0004528
Disease	diastolic blood pressure, body mass index	EFHC2 GLP1R	2.60e-03	16	141	2	EFO_0004340, EFO_0006336
Disease	pancreatic ductal carcinoma (is_implicated_in)	HEATR1 CDK6	2.60e-03	16	141	2	DOID:3587 (is_implicated_in)
Disease	Huntington's disease (biomarker_via_orthology)	BAX ITPR1	2.60e-03	16	141	2	DOID:12858 (biomarker_via_orthology)
Disease	cholesterol in medium HDL measurement	APOB INTS10 NLRC5	2.86e-03	59	141	3	EFO_0021903
Disease	hair colour measurement	FLII ILF3 KBTBD8 REV3L LYST ANKRD27 FANCA FAM13A IGHMBP2	2.88e-03	615	141	9	EFO_0007822
Disease	Charcot-Marie-Tooth disease type 2	IGHMBP2 DYNC1H1	2.94e-03	17	141	2	cv:C0270914
Disease	triglycerides to total lipids in large HDL percentage	APOB INTS10 NLRC5	3.00e-03	60	141	3	EFO_0022330
Disease	cholesterol to total lipids in medium HDL percentage	APOB INTS10 NLRC5	3.00e-03	60	141	3	EFO_0022237
Disease	free cholesterol in HDL measurement	APOB INTS10 NLRC5	3.14e-03	61	141	3	EFO_0022264
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	APOB INTS10 PIGT FAM13A NLRC5	3.17e-03	206	141	5	EFO_0004612, EFO_0020947
Disease	Adenocarcinoma of lung (disorder)	ATR APEX1 NEK1 LATS1 ALB	3.17e-03	206	141	5	C0152013
Disease	Bone marrow hypocellularity	FANCA FANCG	3.30e-03	18	141	2	C1855710
Disease	Malignant Neoplasms	ATR CAPN1 GLP1R CDK6	3.37e-03	128	141	4	C0006826
Disease	total lipids in HDL measurement	APOB INTS10 NLRC5	3.44e-03	63	141	3	EFO_0022307
Disease	thrombin activatable fibrinolysis inhibitor activation peptide measurement	KBTBD8 ITPR1	3.68e-03	19	141	2	EFO_0008582
Disease	total lipids in very large HDL measurement	APOB PIGT NLRC5	3.92e-03	66	141	3	EFO_0022312
Disease	phospholipids in very large HDL measurement	APOB PIGT NLRC5	3.92e-03	66	141	3	EFO_0022298
Disease	cholesterol in very large HDL measurement	APOB PIGT NLRC5	4.45e-03	69	141	3	EFO_0022229
Disease	reticulocyte count	USP34 ATR KBTBD8 HECTD4 SPPL3 EXOSC3 DENND3 PIKFYVE RANBP3L IFRD2 HDGFL2 FBXO34	4.46e-03	1045	141	12	EFO_0007986

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLKVFIDLCLKESTL	PRAMEF33	146	A0A0G2JMD5
LLFLCLLLKTCEPKT	ARSD	21	P51689
LKCRVKKADLPLLTS	EIF2D	276	P41214
ADKAACLLPKLDELR	ALB	196	P02768
LGSLKRVLKDCSIPE	CRYBG3	2376	Q68DQ2
LSRFLLKSCPLLTKE	ABHD2	51	P08910
LSLRKKGLECLVSIL	ARFGEF1	606	Q9Y6D6
LKDSKVFPLLLCITL	GSDME	471	O60443
IFRLLPTKSLVALKC	FBXO34	586	Q9NWN3
NLLCKSPTLLITVRD	ABHD12B	341	Q7Z5M8
LIFSKAKPSVLALCL	CCNG2	196	Q16589
PLCASRNSKAKLRAL	BTBD11	781	A6QL63
LKDECALVPRTLATK	DLGAP1	81	O14490
DSLRLCSKILSKVQP	DOP1A	531	Q5JWR5
LLLKCLTFNPAKRIS	CDK6	276	Q00534
LLPALCDSKIRSKAL	APEX1	291	P27695
SSPTFLLLKKLDSLC	C5AR1	271	P21730
CNLTPDALKSRTIRK	CAPN1	351	P07384
SLKDCLSCLLALLKP	DENND3	121	A2RUS2
LLTFCRAASVLKALP	POLM	176	Q9NP87
IKAECSIRLPKAAKT	MTA2	491	O94776
SLLKPSTKALVLSCK	RAD1	226	O60671
LVLTKQKCPERFLSL	ARHGAP39	371	Q9C0H5
SPKKRLTLSEICEFI	FOXD1	141	Q16676
IIKARLSCDVKLDPR	GPHN	656	Q9NQX3
KGSDLKLLPCTSKAI	INTS10	546	Q9NVR2
KELTNLTRLPCLKDL	LRRC9	181	Q6ZRR7
RKLASSKSCLDPEFL	ARHGEF17	1471	Q96PE2
RLKETPLKCALNSKI	ANKRD27	596	Q96NW4
CRLTLLRPKKDGAAT	MUC16	13531	Q8WXI7
LAICRKLKLDPFLTP	nan	941	O00370
LLEKLLRSCPKVNSV	FAR1	26	Q8WVX9
LTSLPSAICKLSKLK	FLII	281	Q13045
CVSEKLLRKTRESPL	HIGD1B	16	Q9P298
KMLRTCSLPDLSKLF	NEK1	1046	Q96PY6
PSICEFLTKESKLRI	ITPR1	2221	Q14643
EVTRKLLCLDSRKPD	DNAAF2	301	Q9NVR5
KLSPEASDLIIKLCR	LATS1	976	O95835
AALPKATILDLSCNK	LRRC59	36	Q96AG4
LPKSCSLLSLATIKV	LRSAM1	71	Q6UWE0
KLLESLISPDCVLKV	NLRP11	936	P59045
KCRLAKSTLTLIPLL	GLP1R	346	P43220
LSLKILREDKKCPGS	HORMAD2	66	Q8N7B1
KASEALKVVARCRPL	KIF3C	6	O14782
TKDIKRLCKSSRLPL	EFHC2	656	Q5JST6
PKCTKLKCSSLRLIE	F13B	206	P05160
LKVKDIPCSSALLTI	PLXNA4	386	Q9HCM2
CPLQSKKLRKSLICE	CSTL1	101	Q9H114
EALLRCLRTKPSKEL	CES5A	286	Q6NT32
CLRTKPSKELLTLSQ	CES5A	291	Q6NT32
PVLLASLLLICKSSL	FMO4	521	P31512
ILKTCVPDLSDKRLE	DGKA	641	P23743
ALALTSEVCLKGLPK	DIP2B	456	Q9P265
DILTDPSKRCPLKTL	MED15	571	Q96RN5
FLLKSPIAPCSLDKR	CDC25B	466	P30305
LLDALTDPSRKTQKC	GCN1	1581	Q92616
LPLLCRGLAVEAKKT	TUFM	36	P49411
LLKASREKTPLIDLC	FAM120A	811	Q9NZB2
LCEELLSRTSSLLPK	FANCG	416	O15287
SLCLKILKAICKSTP	MIEF1	361	Q9NQG6
SCVPRLCSLTLKKLV	PACS2	36	Q86VP3
QLLLKSKVTAPLECS	CYHR1	286	Q6ZMK1
SKVTAPLECSFLLLK	CYHR1	291	Q6ZMK1
LSQPACVSKLLSLLL	HECTD4	1401	Q9Y4D8
CVSKLLSLLLDQRPS	HECTD4	1406	Q9Y4D8
CSAASLLKLFLRELP	FAM13A	111	O94988
LKLTEPKDLLIFRAC	MPI	406	P34949
LKVDSPDVKRCLNAL	HDGFL2	486	Q7Z4V5
FLLANTLSLCPRVKK	NLRC5	1181	Q86WI3
TLSLCPRVKKVDLRS	NLRC5	1186	Q86WI3
LSKPSLLRARIGCKL	KBTBD8	371	Q8NFY9
AALLPLVTAFCRKLS	SBF1	646	O95248
KGSRLVKPSLCLALL	PLPPR2	231	Q96GM1
LKKSPEALKCRLTEG	KAT6A	951	Q92794
PLLRLACTNTKKLEE	OR6S1	186	Q8NH40
LSGTLLLKRKARACP	BTBD18	201	B2RXH4
SSCIKNPKILLLKCS	PIKFYVE	696	Q9Y2I7
RNLKLSLPDFKELCT	APOB	3311	P04114
TRLTDKLLELCNKPV	ATR	2216	Q13535
VTPLKAKIASLVRKC	C4orf50	71	Q6ZRC1
CLEALKLTTKLQIPR	ESPL1	1011	Q14674
DCIPLLRKTLKDESS	HTT	806	P42858
KECKAVTLAVQPRLL	BTAF1	741	O14981
ILVRQCKSSLPRASK	C4orf45	156	Q96LM5
PTSKLDELLEKLCVS	COG3	391	Q96JB2
RLCDKLGKNLLLTLT	SLC1A2	36	P43004
LLEVEGPLCKKLSLS	FANCA	61	O15360
VLKALCTKVPELIRT	BAX	121	Q07812
SCLLKLISTEVNPKL	CRAMP1	731	Q96RY5
ELVLLCKEKPTTALL	ILF3	111	Q12906
ASEKLCTPLLDLLTR	CEP350	2711	Q5VT06
ECLKLLLRSKPTVDI	ASAP1	651	Q9ULH1
LPKVKRLLSDSTCLP	DNAJC13	1071	O75165
LLRIFLEKSPCTKIL	LYST	1361	Q99698
PLERKLIKESRSTCL	ESCO2	96	Q56NI9
PVLLLDATALKACKV	IFRD2	461	Q12894
SISCIKRLSGLLKVL	DDX24	596	Q9GZR7
FKRCTLLLPTKERLK	FBXO47	121	Q5MNV8
VRLSCLPAFKDLIAK	DYNC1H1	3936	Q14204
CELPKLEKRLRATAE	KIF5A	856	Q12840
ILDFSPSLKTLCKLA	KLHDC3	331	Q9BQ90
TKIPSLIKDGLSCLI	HEATR1	291	Q9H583
AKCIAALISSRPDLL	CAND2	356	O75155
SRKLAQLPDRCTLKT	SEC22A	41	Q96IW7
KVTLGLIRKLLAPDC	EXOSC3	201	Q9NQT5
PDSQKLLRCELESLK	CCDC159	26	P0C7I6
LSPKLSCDTRPLILK	FOCAD	651	Q5VW36
CLETLQKALKVTSLP	MED1	61	Q15648
LKSLPREVSLLQCLK	LRRC30	106	A6NM36
ISDTLELLRPKIKLC	UPF2	976	Q9HAU5
LQSPKKRLTLSEICE	FOXD2	141	O60548
SKLALALAIIRSKPA	MEI4	11	A8MW99
LALKLLQCLKVTDAP	RTTN	1241	Q86VV8
LKPNRLTCTLKLLEY	GTF2H2C;	76	Q6P1K8
LPCVIESLRTLDKKT	TAF7L	156	Q5H9L4
TLSELKSRFPKCAEL	AK9	1711	Q5TCS8
ANLPSILLKVCALLK	UTP20	1841	O75691
KRPCILILDSLKAAS	SENP7	931	Q9BQF6
KLCKTIYPLADLLAR	SVIL	2151	O95425
ALPKDQRPKSLCLSL	NHSL2	591	Q5HYW2
ESLPNSVKCRVLALK	NAP1L5	71	Q96NT1
KKARVVCLPVSLLQL	PKDREJ	1051	Q9NTG1
LAKTCTLRISPDKLN	HUS1	26	O60921
CNLALLLPTVTKEDK	RMDN2	381	Q96LZ7
QAKKALDVLEPLLCS	SH3TC2	811	Q8TF17
SLKDCLPKSAQLLKS	PLK4	876	O00444
LLKKSGCRTPRIELE	RPF2	201	Q9H7B2
SLLPSLCLSEREKKN	SPAG17	486	Q6Q759
DRCLDKAPTVRSKAL	NCAPD3	451	P42695
PVKLRLTVLCAKNLV	SMURF2	11	Q9HAU4
SSCLPEDLSLSKQLK	ZBTB21	861	Q9ULJ3
ILSELKALCADLSPR	XPNPEP1	271	Q9NQW7
RTLLTKCSLFPSLKD	ZNF365	56	Q70YC5
RKVPSLALIELTALC	ARHGAP40	231	Q5TG30
KLLPCSSKAGLSVLL	PIGT	191	Q969N2
DSCPAVSKILERSLK	REV3L	2861	O60673
ALSCLRNPLTKEDKE	TBCE	336	Q15813
LKPNRLTCTLKLLEY	GTF2H2	76	Q13888
KVKSIDLPIQSSLCR	HSPA4L	576	O95757
SLKELQSRGVCLLKL	IGHMBP2	36	P38935
VDICNLRSKLRPAKS	SH3PXD2B	661	A1X283
VRLPSLKVSCLLLSG	SPPL3	181	Q8TCT6
TLSPKAKCLIRSILR	TRIB2	276	Q92519
SQPSRKCLLEKIDVI	RANBP3L	276	Q86VV4
LKKLTLFSTCSPAAR	TMC4	566	Q7Z404
DPVARKALTLLLSVC	TMEM121	106	Q9BTD3
KSQPRKKESLLTCLA	USP12	71	O75317
PLKVFIDLCLKESTL	PRAMEF10	146	O60809
KRLKLLLFAPVACTS	UNC5A	591	Q6ZN44
LDAKKSPLALLAQTC	ZNF503	106	Q96F45
VNLVLLCSEKPSKTL	ZFR	806	Q96KR1
LCSEKPSKTLLSRIA	ZFR	811	Q96KR1
SFLPCSKDALLKRAR	UBN1	416	Q9NPG3
CALLETKKSLPEERI	TASOR2	186	Q5VWN6
KALSDKQSLPLRVVC	USP34	1201	Q70CQ2
AEKRACFKKLPRILS	USP34	2071	Q70CQ2
ALIPTLQELLSKCRT	USP34	3311	Q70CQ2
LCRKASLVKLIKTSP	TTL	71	Q8NG68
AKRLNLATECLPLDK	TRMT10C	326	Q7L0Y3
SCGSPLTLKQKRDLL	UNC79	1736	Q9P2D8
PITRLCSLKEQSILK	nan	156	Q96M85
LQLLRKPCEASSKTV	ART3	146	Q13508